- Home
- ZEPP
as 07-25-2025 4:00pm EST
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
| Founded: | 2013 | Country: | Netherlands |
| Employees: | N/A | City: | N/A |
| Market Cap: | 148.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.06 - $15.85 | Next Earning Date: | 08-03-2025 |
| Revenue: | $181,183,000 | Revenue Growth: | -38.79% |
| Revenue Growth (this year): | 758.69% | Revenue Growth (next year): | N/A |
Latest Zepp Health Corporation News
ZEPP Breaking Stock News: Dive into ZEPP Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Amazfit Introduces Balance 2 Smartwatch and Helio Strap for Smarter Training, Better Recovery and Peak Performance
Business Wire
a month ago
Amazfit Expands Active 2 Lineup with the New Active 2 Square — All the Same Features, Now in a Sleek Square Design
PR Newswire
2 months ago
Zepp Health Corporation Reports First Quarter 2025 Unaudited Financial Results
PR Newswire
3 months ago
Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025
PR Newswire
3 months ago
Zepp Health Corporation Files 2024 Annual Report on Form 20-F
Business Wire
4 months ago
Amazfit Announces the Bip 6 Smartwatch: The Everyday Smartwatch for Every Moment
Simply Wall St.
4 months ago
Zepp Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
PR Newswire
4 months ago
Zepp Health Corporation Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results
Compare ZEPP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZEPP Zepp Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.